GW Pharmaceuticals has released further details of its cannabis development pipeline.
With Epidiolex approved in the US last year it is also expecting approval for...
CHANGES to immigration policy post-Brexit has resulted in a shortage of seasonal labour at UK-based medicinal cannabis cultivation sites, claims the company that owns...
LEADING UK cannabis company GW Pharmaceuticals has received the Queen’s Award for Enterprise 2021 in recognition of its ground-breaking work in creating the world’s...
IRISH firm Jazz Pharmaceuticals has agreed to purchase UK medical cannabis trailblazer GW Pharmaceuticals for $7.2bn.
The deal will be the biggest ever transaction in...
THE emerging cannabis industry is moving up the agenda for the pharmaceutical industry with two significant deals announced in the last few months.
Over the...